SCHEMBL19684424

SCHEMBL19684424

CCCC(C)(C)n1ncc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 2/20 0.40
▸ RECQL P46063 2/20 0.40
▸ ASAH1 Q13510 1/20 0.39
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ POLB P06746 4/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KMO O15229 1/20 0.36
▸ PDE10A Q9Y233 3/20 0.35
▸ TSHR P16473 2/20 0.34
▸ RAB9A P51151 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CASP1 P29466 2/20 0.33
▸ CASP7 P55210 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19738739 0.86 RECQL (0.42) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL26622638 0.78 CHEK1 (0.36) MAPTKDM4EALDH1A1GAAADRA2A
SCHEMBL30449976 0.78 RECQL (0.43) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL10050859 0.78 RECQL (0.43) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL28172026 0.77 CYP11B1 (0.42) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL22559859 0.77 RECQL (0.40) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL26632648 0.75 TLR8 (0.31) —
SCHEMBL14155122 0.75 CYP11B1 (0.37) SLC6A2RECQLASAH1CYP11B1CYP11B2
SCHEMBL26651181 0.75 MKNK1 (0.36) HSD17B10TSHRRAB9ANPC1MEN1
SCHEMBL26622927 0.73 MCHR1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227324-B2 2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2019-03-12 — — US disclosed
US-20170349568-A1 2-MORPHOLIN-4,6-DISUBSTITUTED PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF YANGTZE RIVER PHARMACEUTICAL GROUP CO., LTD. (CN) 2017-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349568-A1 2-MORPHOLIN-4,6-DISUBSTITUTED PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF PIK3CA, PIK3CD, PIK3CG SLC6A2 2640/4885RECQL 572/4885ASAH1 1302/4885
US-10227324-B2 2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof PIK3CA, PIK3CD, PIK3CG SLC6A2 2640/4885RECQL 572/4885ASAH1 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback